David Miles, MD, discusses Avastin studies

David Miles, MD, of Mount Vernon Hospital in the United Kingdom, discusses two pivotal studies from SABCS on the angiogenesis inhibitor drug, Avastin.

PRODUCED BY DALLAS ALLEN

Adding Avastin May Slow Disease Progression

BY LAURA BEIL

ARTICLE ORIGINALLY PUBLISHED
IN WEB EXCLUSIVES

Please be patient, this video may take several seconds to a few minutes to begin playing,
depending on your download speed.

The latest version of Quicktime is recommended to view this video.